tanshinone ii a has been researched along with moxifloxacin in 1 studies
Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) |
---|---|---|---|---|---|
61 | 0 | 41 | 3,157 | 552 | 1,690 |
Protein | Taxonomy | tanshinone ii a (IC50) | moxifloxacin (IC50) |
---|---|---|---|
DNA gyrase subunit B | Staphylococcus aureus | 5.1033 | |
DNA gyrase subunit A | Escherichia coli K-12 | 1.4 | |
DNA gyrase subunit B | Escherichia coli K-12 | 1.4 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.8 | |
DNA gyrase subunit A | Staphylococcus aureus | 7.25 | |
DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 8.525 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 8.66 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
1 other study(ies) available for tanshinone ii a and moxifloxacin
Article | Year |
---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |